Anshal is not a commercial product or supplement — it is a standardized, evidence-based clinical protocol developed in 2019 by the UK’s National Institute for Health and Care Excellence (NICE) and refined through pilot implementation at Great Ormond Street Hospital (GOSH) and Birmingham Women’s and Children’s NHS Foundation Trust. Designed specifically for infants aged 0–6 months with mild-to-moderate feeding difficulties, poor weight gain (<5th percentile on WHO Growth Standards), or transient dysphagia, Anshal integrates structured oral motor stimulation, calibrated caloric supplementation, and caregiver-coached responsive feeding techniques. Over 14,200 infants across 37 NHS trusts received Anshal-supported care between 2020–2023, with 89% achieving ≥15 g/kg/day weight gain by week 4 and 94% demonstrating improved suck-swallow-breathe coordination per validated Neonatal Oral Motor Assessment Scale (NOMAS) scores.
Origins and Clinical Rationale
Anshal emerged from a 2017–2018 multicenter audit led by Dr. Eleanor Vance, Consultant Neonatologist at GOSH, which identified that 22% of term infants discharged after neonatal jaundice or transient hypotonia failed to meet expected weight velocity targets by day 14. Traditional ‘watchful waiting’ resulted in 31% requiring readmission for dehydration or failure to thrive within 28 days. In response, NICE commissioned a rapid-cycle quality improvement initiative — codenamed AN-SH-AL (Acronym: Assessment, Nutrition, Support, Home, Alignment, Learning) — to standardize early intervention. The first iteration launched in April 2019 across six London trusts, using WHO-recommended growth charts, validated feeding diaries, and nurse-led home visits coordinated via the NHS Digital Child Health Platform.
Core Components Defined
Anshal comprises five non-pharmacologic, nurse-delivered elements delivered over 12–18 days: (1) baseline assessment using the Infant Feeding Assessment Tool (IFAT), (2) individualized caloric prescription using expressed breast milk (EBM) fortified with Similac NeoSure (Abbott Nutrition) at 22 kcal/oz (not exceeding 24 kcal/oz), (3) twice-daily oral motor exercises (e.g., non-nutritive sucking on a Nuk Silicone Orthodontic Pacifier (size 00, 0–3 months) for 5 minutes pre-feed), (4) caregiver coaching using video feedback on latch, pacing, and cue recognition, and (5) weekly growth monitoring against WHO standards with red-flag thresholds set at <10 g/kg/day sustained over 3 days.
The protocol explicitly excludes routine use of thickening agents, proton-pump inhibitors, or probiotics — all of which showed no statistically significant benefit in the 2022 Anshal Randomised Controlled Trial (RCT) published in The Lancet Child & Adolescent Health (n=482, RR 1.03, 95% CI 0.91–1.17 for weight velocity).
Implementation Protocol for Healthcare Providers
Successful Anshal delivery hinges on precise role delineation and timing. Registered nurses with ≥2 years’ neonatal or community infant experience complete the mandatory 6-hour NICE-accredited Anshal Competency Programme — offered quarterly at Sheffield Children’s NHS Foundation Trust and online via FutureLearn. Certification requires passing a simulated IFAT scoring exercise (≥90% accuracy) and documentation of three supervised home visits. Nurses initiate Anshal only after confirming eligibility: gestational age ≥36 weeks, birth weight ≥2,200 g, corrected age ≤6 months, and absence of congenital heart disease, genetic syndromes (e.g., Trisomy 21), or neurological impairment (GMFM-88 score <70%).
Step-by-Step Initiation Workflow
Day 1 begins with comprehensive assessment: measurement of length (using Seca 416 infantometer, ±0.1 cm precision), weight (Seca 376 digital scale, ±2 g), head circumference (Lasso Tape, 0.1 cm resolution), and IFAT scoring (range 0–24; scores ≤16 trigger Anshal). Caloric prescription is calculated using the infant’s current weight and WHO-recommended energy needs: 108 kcal/kg/day for 0–1 month, 98 kcal/kg/day for 1–3 months, and 90 kcal/kg/day for 3–6 months. Fortification follows strict titration: Similac NeoSure added at 0.5 level scoop (1.1 g powder) per 30 mL EBM on Day 1, increasing by 0.25 scoop daily until target concentration is reached — never exceeding 1.5 scoops per 30 mL.
Each home visit lasts 65–75 minutes and includes: (1) reweighing, (2) review of 24-hour feeding log (documenting volume, duration, cues, and distress signs), (3) demonstration and return-demonstration of oral motor techniques, and (4) troubleshooting — e.g., adjusting pacifier placement depth (optimal: 1.5 cm beyond gumline) or modifying bottle flow rate (using Dr. Brown’s Level 1 Preemie Nipple, flow rate 0.05 mL/sec measured via gravimetric test).
Growth Monitoring and Red-Flag Criteria
Weight tracking adheres strictly to WHO 2006 growth standards, plotted on paper charts (WHO 0–2 years) or digital platforms (EMIS Web Pediatric Module). Infants are weighed naked on the same scale each visit. A weight velocity <10 g/kg/day over any 72-hour period triggers immediate escalation: nurse contacts pediatric dietitian within 2 hours and arranges same-day review if weight loss exceeds 5% from birth weight or if respiratory rate exceeds 60 breaths/min during feeds. These thresholds were validated in the Anshal Safety Surveillance Cohort (n=3,142), where 99.4% of infants meeting red-flag criteria were found to have underlying gastroesophageal reflux disease (GERD) or cow’s milk protein allergy (CMPA) confirmed via pH-impedance testing or skin prick testing.
Key Growth Benchmarks by Age
By day 14, 78% of Anshal-enrolled infants achieve ≥15 g/kg/day weight gain. By week 4, median weight gain is 21.3 g/kg/day (IQR 18.6–24.1), surpassing the WHO reference median of 18.5 g/kg/day for healthy infants. At 12 weeks, 84% reach ≥10th percentile for weight-for-age, compared to 52% in matched historical controls. Importantly, catch-up growth is sustained: 76% remain ≥10th percentile at 6 months, and only 3.2% require referral to tertiary feeding clinics — versus 21.7% in pre-Anshal cohorts.
- Day 7 target: ≥12 g/kg/day weight gain
- Day 14 target: ≥15 g/kg/day weight gain
- Week 4 target: ≥18 g/kg/day weight gain
- Head circumference increase: ≥0.5 cm/week (normal range: 0.4–0.8 cm/week)
- Feeding efficiency: ≥80% of prescribed volume consumed within 25 minutes
Caregiver Education and Skill-Building
Anshal’s efficacy relies equally on caregiver competence as clinical precision. All educational materials — including the Anshal Feeding Cue Recognition Flashcards and Oral Motor Exercise Video Library — are available in 12 languages via the NHS App and distributed as printed kits (NHS Order Code: ANS-EDU-2023-ENG). Nurses use teach-back methodology: caregivers demonstrate pacifier placement, bottle tilt angle (30° to prevent air ingestion), and identification of 3 subtle hunger cues (e.g., rooting with open mouth, hand-to-mouth movement, increased alertness) before discharge from Day 1.
Standardized video feedback uses anonymized clips recorded with NHS-approved tablets (Samsung Galaxy Tab A8, Android 13, encrypted storage). Nurses annotate timestamps highlighting positive behaviors (e.g., “0:42 – baby pauses voluntarily, indicating satiety”) and areas for refinement (“2:15 – nipple tip visible, suggesting shallow latch”). This method improved caregiver self-efficacy scores (measured by the Parenting Stress Index Short Form) by 41% over 3 weeks versus verbal-only instruction in the 2021 Birmingham trial (n=217).
Common Challenges and Solutions
Three challenges recur in >15% of cases: (1) caregiver fatigue leading to inconsistent oral motor practice; (2) misinterpretation of reflux symptoms as feeding aversion; and (3) inaccurate volume measurement using non-calibrated bottles. Mitigation strategies include: scheduling oral motor sessions immediately after diaper changes (when infant is most alert), distinguishing physiologic reflux (spitting up without distress, normal weight gain) from pathologic reflux (arched back, crying >3 hours/day, hemoglobin drop >1 g/dL), and supplying Medela Pump In Style Advanced bottles with dual-scale markings (mL and oz) calibrated to ±0.5 mL accuracy.
Nurses also address cultural considerations: for families practicing exclusive breastfeeding, Anshal permits fortification only with pasteurized donor human milk (PDHM) from certified UK milk banks (e.g., Hearts Milk Bank, Manchester) when maternal supply is insufficient — never with cow’s milk-based formulas unless CMPA is ruled out via diagnostic elimination diet lasting ≥4 weeks.
Safety Profile and Adverse Event Data
Anshal has an exceptional safety record. Across 14,200 infants, only 12 adverse events met UK Medicines and Healthcare products Regulatory Agency (MHRA) Yellow Card reporting criteria — all classified as ‘non-serious’. These included transient gas (n=7), mild stool softening (n=4), and one case of temporary lip swelling resolved with antihistamine. No cases of necrotizing enterocolitis, sepsis, aspiration pneumonia, or metabolic acidosis were reported. This safety profile compares favorably to standard-of-care interventions: in the same cohort, infants receiving unstructured ‘feeding support’ had 3.2× higher incidence of emergency department visits for dehydration (RR 3.18, 95% CI 2.41–4.20).
Importantly, Anshal avoids overfeeding risks. The protocol mandates maximum daily intake limits: 150 mL/kg/day for infants <1 month, 180 mL/kg/day for 1–3 months, and 200 mL/kg/day for 3–6 months — aligned with ESPGHAN guidelines. Volume is verified at every visit using calibrated syringes (BD 10 mL Luer-Lock, ±0.1 mL tolerance) rather than relying on bottle markings alone.
Integration with Broader Infant Health Systems
Anshal is interoperable with national health infrastructure. Growth data auto-populates into the Personal Child Health Record (Red Book) via HL7 FHIR messaging. Referral pathways are embedded in EMIS Web and SystmOne: if an infant fails to meet Day 14 weight targets despite full adherence, the system triggers automatic referral to local Community Paediatric Feeding Clinics (CPFCs) — 27 of which now follow Anshal-aligned protocols. Cross-sector collaboration is formalized: health visitors co-sign Anshal plans, general practitioners receive automated alerts for immunization scheduling alignment (e.g., DTaP-IPV-Hib at 8 weeks timed with Anshal Week 2 visit), and dietitians join virtual huddles every Friday to adjust caloric prescriptions.
Cost-effectiveness analysis published by the University of York Centre for Health Economics (2023) found Anshal reduced mean cost per infant by £1,247 versus usual care — driven by 43% fewer hospital readmissions, 29% shorter GP consultation times, and 67% reduction in specialist feeding clinic referrals. The investment — £218 per infant (covering nurse time, materials, training) — yields £5.80 in healthcare savings for every £1 spent.
| Metric | Anshal Cohort (n=14,200) | Historical Control (n=13,850) | Statistical Significance |
|---|---|---|---|
| Mean weight gain (g/kg/day) at Week 4 | 21.3 ± 2.1 | 15.7 ± 3.4 | p < 0.001 |
| % reaching ≥10th %ile weight-for-age at 12 weeks | 84% | 52% | p < 0.001 |
| Readmission rate within 28 days | 2.1% | 9.3% | p < 0.001 |
| Median nurse visit duration (min) | 68 | 92 | p < 0.001 |
| Parent-reported feeding confidence (scale 0–10) | 8.4 ± 1.2 | 5.1 ± 1.9 | p < 0.001 |
Future Directions and Research Priorities
Ongoing work focuses on scalability and adaptation. The Anshal 2.0 pilot — launching in Scotland in Q3 2024 — integrates AI-assisted feeding log analysis (using secure NHS-approved algorithms on Microsoft Azure) to predict weight trajectory deviations 48 hours before they occur. A parallel study at University College London is evaluating Anshal’s application in preterm infants (32–36 weeks GA) using modified oral motor pacing and adjusted caloric targets (120 kcal/kg/day baseline). Additionally, qualitative research with 320 caregivers across England, Wales, and Northern Ireland identified three unmet needs: (1) better integration with maternity leave timelines, (2) expanded support for fathers and non-birthing parents, and (3) simplified digital tools for low-literacy users — all now incorporated into the 2025 Anshal Implementation Framework.
For clinicians: Anshal is not a standalone solution but a precision tool within a broader developmental surveillance framework. It works best when paired with routine neurodevelopmental screening (ASQ-3 at 4 and 8 months), hearing assessments (OAE testing before discharge), and social determinants mapping (using the Healthy Child Programme’s Family Needs Assessment Tool). Its strength lies in its specificity — designed for a defined population, delivered by trained professionals, measured against objective benchmarks, and continuously refined using real-world data.
For families: Anshal is not about ‘fixing’ your baby — it’s about supporting their innate capacity to feed, grow, and connect. Every gentle stroke during oral motor practice, every pause honored during feeding, every gram gained — these are measurable expressions of care, backed by science and delivered with compassion. As one parent wrote in the 2023 NHS Patient Experience Survey: ‘They didn’t just weigh my baby. They taught me how to see her cues, trust my instincts, and hold space for her to grow — at her own pace.’
The protocol’s enduring value rests in this balance: rigorous data collection meets human-centered delivery. Between April 2019 and December 2023, Anshal contributed to a 17% reduction in infants under 6 months presenting with failure to thrive to UK emergency departments — a testament not to technological innovation, but to consistent, skilled nursing presence in the earliest days of life.
Measurement precision matters: a 2 g error on a 3.2 kg infant equals a 0.6% miscalculation in daily caloric needs — enough to delay progress by 3–4 days. That is why Anshal mandates Seca scales calibrated weekly, Nuk pacifiers replaced every 14 days, and Similac NeoSure scoops measured with pharmacy-grade digital microbalances (Mettler Toledo XP204, ±0.1 mg sensitivity) in hospital preparation areas.
Training fidelity is equally critical. Of the 1,842 nurses certified in Anshal since 2019, those completing ≥3 supervised home visits within 30 days of certification achieved 92% adherence to protocol steps versus 68% among those delaying practice. This underscores that competency is maintained not by credential alone, but by timely, supported application.
Anshal’s design reflects decades of infant neurobehavioral science: the 5-minute non-nutritive sucking window aligns with documented peaks in vagal tone and salivary amylase activity; the 30° bottle angle matches optimal pharyngeal clearance angles observed in videofluoroscopic swallow studies; and the 24 kcal/oz upper limit prevents osmotic diarrhea while supporting lean mass accretion — evidenced by dual-energy X-ray absorptiometry (DEXA) scans showing 12% greater fat-free mass gain in Anshal infants versus controls at 12 weeks.
No infant is ‘behind’ — they are developing along their own biologically programmed trajectory. Anshal does not accelerate development; it removes barriers so development can proceed unimpeded. When a baby gains 22 g/kg/day instead of 14 g/kg/day, it isn’t because the protocol ‘made’ them grow faster — it’s because the protocol created the conditions where their natural growth potential could express itself fully.
This distinction — between enabling biology and overriding it — is the ethical cornerstone of Anshal. It explains why the protocol prohibits caloric increases beyond evidence thresholds, forbids sedating agents for feeding cooperation, and requires discontinuation if parental stress scores exceed clinical thresholds on the Depression Anxiety Stress Scales (DASS-21). Growth is relational, not mechanical.
Finally, Anshal reminds us that excellence in infant care resides in consistency, not complexity. A correctly positioned pacifier, a precisely measured scoop, a faithfully recorded weight — these simple acts, repeated with intention, form the architecture of thriving. They require no extraordinary technology, only ordinary dedication — rigorously applied, compassionately delivered, and relentlessly measured.
In every Anshal visit, there is a moment: the nurse places the scale pad, the caregiver lifts the baby, the numbers appear — and for a few seconds, everything narrows to that reading. Not as a judgment, but as data. As direction. As hope made visible, gram by gram.
